Correlation Between Caesars Entertainment, and CRISPR Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Caesars Entertainment, and CRISPR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caesars Entertainment, and CRISPR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caesars Entertainment, and CRISPR Therapeutics AG, you can compare the effects of market volatilities on Caesars Entertainment, and CRISPR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caesars Entertainment, with a short position of CRISPR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caesars Entertainment, and CRISPR Therapeutics.

Diversification Opportunities for Caesars Entertainment, and CRISPR Therapeutics

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between Caesars and CRISPR is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Caesars Entertainment, and CRISPR Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CRISPR Therapeutics and Caesars Entertainment, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caesars Entertainment, are associated (or correlated) with CRISPR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CRISPR Therapeutics has no effect on the direction of Caesars Entertainment, i.e., Caesars Entertainment, and CRISPR Therapeutics go up and down completely randomly.

Pair Corralation between Caesars Entertainment, and CRISPR Therapeutics

Assuming the 90 days trading horizon Caesars Entertainment, is expected to generate 6.74 times less return on investment than CRISPR Therapeutics. But when comparing it to its historical volatility, Caesars Entertainment, is 3.34 times less risky than CRISPR Therapeutics. It trades about 0.09 of its potential returns per unit of risk. CRISPR Therapeutics AG is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  2,814  in CRISPR Therapeutics AG on April 21, 2025 and sell it today you would earn a total of  1,694  from holding CRISPR Therapeutics AG or generate 60.2% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Caesars Entertainment,  vs.  CRISPR Therapeutics AG

 Performance 
       Timeline  
Caesars Entertainment, 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Caesars Entertainment, are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Caesars Entertainment, may actually be approaching a critical reversion point that can send shares even higher in August 2025.
CRISPR Therapeutics 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in CRISPR Therapeutics AG are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, CRISPR Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Caesars Entertainment, and CRISPR Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Caesars Entertainment, and CRISPR Therapeutics

The main advantage of trading using opposite Caesars Entertainment, and CRISPR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caesars Entertainment, position performs unexpectedly, CRISPR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CRISPR Therapeutics will offset losses from the drop in CRISPR Therapeutics' long position.
The idea behind Caesars Entertainment, and CRISPR Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Valuation
Check real value of public entities based on technical and fundamental data
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments